Chase Pharmaceuticals is a pharmaceuticals company based out of 1825 K St NW, Washington, District of Columbia, United States.
View Top Employees from Chase PharmaceuticalsWebsite | http://www.chasepharmaceuticals.com |
Revenue | $13 million |
Funding | $22.8 million |
Employees | View employees |
Founded | 2007 |
Address | 1825 K St. Nw Ste. 520, Washington, D.C, District of Columbia 20006, US |
Phone | (202) 223-7002 |
Technologies |
JavaScript,
HTML,
PHP
+10 more
(view full list)
|
Industry | Biotechnology, Pharmaceutical Manufacturing, Pharmaceuticals, Science and Engineering, Healthcare, Health Care, Medical |
Competitors | Alector, Alzheon, Inc. | Preserving Future Memories, Gismo Therapeutics Inc., PHARNEXT |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 3254 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies |
Looking for a particular Chase Pharmaceuticals employee's phone or email?
The Chase Pharmaceuticals annual revenue was $13 million in 2023.
Chase Pharmaceuticals is based in Washington, D.C, District of Columbia.
The NAICS codes for Chase Pharmaceuticals are [3254, 32, 325].
The SIC codes for Chase Pharmaceuticals are [28, 283].